Comparative cost-effectiveness analysis between darunavir/ritonavir and other protease inhibitors in treatment-naive human immunodeficiency syndrome type 1-infected patients in Spain

Autor: Smets, E, Brogan, AJ, Hill, A, Adriaenssen, I, Sawyer, AW, Domingo-Pedrol, P, Gostkorzewicz, J, Ledesma, F

Publikováno v: ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

Introduction: GESIDA (AIDS Study Group) has proposed preferred regimens of antiretroviral treatment as initial therapy in HIV infected patients. The objective of this analysis is to compare the costs and effectiveness of darunavir/r QD and other rito

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::3d735c6e4d66d9f6a5dce27cb0abc7d7
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=9758

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Poly-Target Selection Identifies Broad-Spectrum RNA Aptamers.

Autor: Alam KK; Department of Biochemistry, University of Missouri, Columbia, MO, USA; Bond Life Sciences Center, University of Missouri, Columbia, MO, USA., Chang JL; Bond Life Sciences Center, University of Missouri, Columbia, MO, USA; Department of Molecular Microbiology and Immunology, University of Missouri, Columbia, MO, USA., Lange MJ; Bond Life Sciences Center, University of Missouri, Columbia, MO, USA; Department of Molecular Microbiology and Immunology, University of Missouri, Columbia, MO, USA., Nguyen PDM; Department of Biochemistry, University of Missouri, Columbia, MO, USA; Bond Life Sciences Center, University of Missouri, Columbia, MO, USA., Sawyer AW; Department of Biochemistry, University of Missouri, Columbia, MO, USA; Bond Life Sciences Center, University of Missouri, Columbia, MO, USA., Burke DH; Department of Biochemistry, University of Missouri, Columbia, MO, USA; Bond Life Sciences Center, University of Missouri, Columbia, MO, USA; Department of Molecular Microbiology and Immunology, University of Missouri, Columbia, MO, USA; Department of Biological Engineering, University of Missouri, Columbia, MO, USA. Electronic address: burkedh@missouri.edu.

Publikováno v: Molecular therapy. Nucleic acids [Mol Ther Nucleic Acids] 2018 Dec 07; Vol. 13, pp. 605-619. Date of Electronic Publication: 2018 Oct 24.

Resistance at virological failure using boosted protease inhibitors versus nonnucleoside reverse transcriptase inhibitors as first-line antiretroviral therapy--implications for sustained efficacy of ART in resource-limited settings.

Autor: Hill A; Pharmacology Research Laboratories, Liverpool University, United Kingdom., McBride A, Sawyer AW, Clumeck N, Gupta RK

Publikováno v: The Journal of infectious diseases [J Infect Dis] 2013 Jun 15; Vol. 207 Suppl 2, pp. S78-84.

Potent Inhibition of HIV-1 Reverse Transcriptase and Replication by Nonpseudoknot, "UCAA-motif" RNA Aptamers.

Autor: Whatley AS; 1] Department of Molecular Microbiology and Immunology, University of Missouri, Columbia, Missouri, USA [2] Current addresses: Department of Veterans Affairs Office of Research and Development (10P9), Washington DC, USA., Ditzler MA, Lange MJ, Biondi E, Sawyer AW, Chang JL, Franken JD, Burke DH

Publikováno v: Molecular therapy. Nucleic acids [Mol Ther Nucleic Acids] 2013 Feb 05; Vol. 2, pp. e71. Date of Electronic Publication: 2013 Feb 05.